Fulgent Genetics Inc. (FLGT)
NASDAQ · Healthcare
Fulgent Genetics Inc. Shareholder Equity 2014–2025
Fulgent Genetics Inc. annual shareholder equity history from 2015 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Fulgent Genetics Inc. shareholder equity as of December 31, 2025: 1.11B, a 1.87% decrease year-over-year.
- Fulgent Genetics Inc. shareholder equity for 2025 were 1.11B, a 1.87% decrease from 2024.
- Fulgent Genetics Inc. shareholder equity for 2024 were 1.13B, a 0.25% decrease from 2023.
- Fulgent Genetics Inc. shareholder equity for 2023 were 1.14B, a 10.31% decrease from 2022.
- Fulgent Genetics Inc. shareholder equity for 2022 were 1.27B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Fulgent Genetics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,112 |
| 2024 | $1,133 |
| 2023 | $1,136 |
| 2022 | $1,267 |
| 2021 | $1,159 |
| 2020 | $569 |
| 2019 | $83 |
| 2018 | $51 |
| 2017 | $54 |
| 2016 | $54 |
| 2015 | $5 |
Fulgent Genetics Inc. Shareholder Equity — FAQ
Fulgent Genetics Inc. (FLGT) shareholder equity over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FLGT's shareholder equity history?
The chart and table above show Fulgent Genetics Inc.'s shareholder equity by year and by quarter, including the growth rate.